Cart
sales@molnova.com
OU749
CAS No. 519170-13-9
OU749( —— )
Catalog No. M27513 CAS No. 519170-13-9
OU749 is a γ-glutamyl transferase (GGT) inhibitor with an intrinsic Ki of 17.6 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 60 | Get Quote |
|
| 5MG | 87 | Get Quote |
|
| 10MG | 167 | Get Quote |
|
| 25MG | 358 | Get Quote |
|
| 50MG | 537 | Get Quote |
|
| 100MG | 767 | Get Quote |
|
| 500MG | 1557 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOU749
-
NoteResearch use only, not for human use.
-
Brief DescriptionOU749 is a γ-glutamyl transferase (GGT) inhibitor with an intrinsic Ki of 17.6 μM.
-
DescriptionOU749 is a γ-glutamyl transferase (GGT) inhibitor with an intrinsic Ki of 17.6 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetTransferase
-
RecptorTNF-α|PGE|p38|Mitochondrial Metabolism|PTEN-induced kinase 1 (PINK1)|Bacterial|Autophagy
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number519170-13-9
-
Formula Weight361.43
-
Molecular FormulaC16H15N3O3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (345.84 mM)
-
SMILESCOc1ccc(Cc2nnc(NS(=O)(=O)c3ccccc3)s2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shin SW, et al. Antagonizing effects and mechanisms of afzelin against UVB-induced cell damage. PLoS One. 2013 Apr 23;8(4):e61971.
molnova catalog
related products
-
CBHcy
CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
-
Norcantharidin
Norcantharidin is a synthetic anticancer compound which is a dual inhibitor for c-Met and EGFR in human colon cancers.
-
AZD3988
AZD3988 is an orally active and highly potent inhibitor of diacylglycerol acyltransferase-1 (DGAT-1) for the study of diabetes and obesity.
